10x Genomics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $817.6M | $587.4M |
| FY2022 | — | $805.7M | $219.7M |
| FY2023 | — | $741.0M | $359.3M |
| FY2024 | — | $710.1M | $344.1M |
| FY2025 | — | $796.3M | $474.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $817.6M | $587.4M |
| FY2022 | — | $805.7M | $219.7M |
| FY2023 | — | $741.0M | $359.3M |
| FY2024 | — | $710.1M | $344.1M |
| FY2025 | — | $796.3M | $474.0M |